RBC Capital Markets maintained the shares of KTWO in report on Tuesday, July 18 with "Buy" rating. Needham maintained the shares of KTWO in report on Wednesday, November 4 with "Buy" rating.
In a statement issued on Monday October 09, 2017 Needham dropped the price target of K2M Group (NASDAQ:KTWO) from $29.00 to $27.00 indicating a possible upside of 0.24%. K2M Group Holdings, Inc. has had 6 insider trades in the last 3 months, including 0 open market buys and 6 sells. Cowen and Company reiterated a "buy" rating and issued a $26.00 target price on shares of K2M Group Holdings in a research note on Wednesday, July 19th.
Among 11 analysts covering K2M Group Holdings (NASDAQ:KTWO), 10 have Buy rating, 0 Sell and 1 Hold. Net profit margin of K2M Group Holdings, Inc. The rating was maintained by RBC Capital Markets on Tuesday, July 18 with "Buy". K2M Group Holdings has an average rating of Buy and an average target price of $25.60.
Shares of K2M Group Holdings (KTWO) traded up 1.805% during mid-day trading on Tuesday, hitting $18.335. The company had a trading volume of 413,776 shares. A total of 1.72 Million shares exchanged hands, whereas the company's average trading volume stands at 1.17 Million shares.
Cytori Therapeutics (NASDAQ:CYTX)'s distance from 20 day simple moving average is 0.4276 along with distance from 50 day simple moving average of 0.3729 whereas its distance from 200 day simple moving average is 0.8245. The company rocked its 52-Week High of $25.99 and touched its 52-Week Low of $16.32. The company beat the analyst EPS Estimate with the difference of $0.11. Analysts review historical return data when trying to predict future returns or to estimate how a security might react to a particular situation, such as a drop in consumer demand. It is 0.00% or $0 reaching $2.35 per share. Revenue during the quarter was $16.08 billion, representing 0% growth from $16.1 billion in year-ago quarter. Equities analysts predict that K2M Group Holdings will post ($0.81) earnings per share for the current fiscal year.
K2M Group Holdings (NASDAQ:KTWO) last released its quarterly earnings results on Tuesday, August 1st. If you are reading this story on another website, it was illegally copied and reposted in violation of United States and worldwide copyright and trademark laws. The stock of K2M Group Holdings Inc (NASDAQ:KTWO) has "Market Outperform" rating given on Friday, April 8 by JMP Securities. (NASDAQ:KTWO)'s performance this year to date is -10.13%.
The most recent open market insider trade was Automatic Sell of 1,332 shares on a day where the closing price was 23.3. The stock has been active on the tape, now trading at $17.77, down from yesterday's close by -18.41%. Following the completion of the transaction, the insider now owns 200,629 shares in the company, valued at approximately $4,674,655.70. The disclosure for this sale can be found here. The company maintains price to book ratio of 1.48.
Several hedge funds have recently bought and sold shares of the company. TimesSquare Capital Management LLC raised its holdings in K2M Group Holdings by 31.5% during the second quarter. There has been an observed change of -15.09% in the ownership of the shares in the past six months. Beta value of the stock stands at 1.44. Schroder Investment Management Group increased its holdings in K2M Group Holdings by 1.6% in the second quarter. They now have a United States dollars 30 price target on the stock.
06/02/2014 - Wells Fargo began new coverage on K2M Group Holdings, Inc. giving the company a "outperform" rating. Its up 37.5% from 800 shares previously. Legal & General Group Plc raised its stake in K2M Group Holdings by 9.1% in the 1st quarter.
K2M Group Holdings, Inc.is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company's solutions are focused on achieving three-dimensional Total Body Balance. The Company's spine products are used by spine surgeons to treat spinal pathologies, such as deformity, trauma and tumor.